IDO2 and neoplasm: demonstrated that tumor-infiltrating Tregs promote immune evasion via the expression of T-cell markers, type I interferon markers, programmed cell death-ligand 1, indoleamine 2, 3-dioxygenase, and FOXP3 (80).